Dad Beats Aggressive Brain Cancer After Breakthrough Drug – Now He’s Tumor-Free

A breakthrough drug is fighting brain cancer head-on. Glioblastoma is considered one of the most aggressive and deadly forms of brain cancer. It’s responsible for claiming the lives of more than 10,000 people in the United States each year. Sadly, there’s no known cure for this disease, and most people who are diagnosed with it are only expected to live for about nine months. Ben Trotman was diagnosed with glioblastoma in October 2022 at just 40 years old.Marie Mangan Doctors usually try to ease the symptoms and give patients a bit more time through surgery to remove the tumor, along with rounds of radiation and chemotherapy to target the cancer cells. But now, there’s hope on the horizon. Researchers at University College London Hospitals (UCLH) have started a new trial involving an immunotherapy drug called ipilimumab. Sold under the name Yervoy, this drug is a monoclonal antibody designed to help the immune system recognize cancer and fight it. Doctors are feeling hopeful because one patient—a 43-year-old dad from the UK showed no signs of cancer after taking ipilimumab before starting his usual glioblastoma treatment. “The crucial element of this trial is that patients will have their immune system boosted by… CONTINUE READING…